来源：新浪证券-红岸工作室 2月24日，*ST新潮涨1.95%，成交额1.13亿元，换手率0.42%，总市值284.94亿元。 异动分析 天然气+俄乌冲突概念+页岩气+人民币贬值受益 2、俄乌冲突可能恶化俄罗斯油气出口前景，原油中枢或超预期。公司的主营业务为石油及天然气的勘 探、开采及销售。公司的主要产品为原油、天然气。 技术面：筹码平均交易成本为3.38元 3、2022年9月20日互动易：至2022年6月30日，公司已上线页岩油净井数达 638 口。至 2021 年度末，按 照美国 SEC 标准参数评估的已探明油气经济可采储量（P1）达 3.15亿桶油当量，其中已探明、已开 发、在生产油气储量 （PDP）占比约 52%。 4、根据2024年年报，公司海外营收占比为100.00%，受益于人民币贬值。 (免责声明：分析内容来源于互联网，不构成投资建议，请投资者根据不同行情独立判断) 资金分析 今日主力净流入-23.79万，占比0%，行业排名4/4，连续3日被主力资金减仓；所属行业主力净流入6.02 亿，当前无连续增减仓现象，主力趋势不明显。 区间今日近3日近5日近10日近20日主力净流入-23.79万-230. ...

2月12日，ST联创（维权）公告，公司拟以集中竞价交易方式回购股份。回购价格不超3.26元/股。资金 来源为自有资金。 ST联创当前最新价为6.29元，今年以来，ST联创股价累计上涨4.31%。此次公告拟定的最高回购价格， 比现价低48.17%。 股票回购往往被视为一种稳价措施。指上市公司用现金等方式从股票市场买回自家公司已经发行在外的 一定数额的股票。一般来讲，回购后可以注销，也可以用于实施员工持股计划或股权激励计划等。 资料显示，山东联创产业发展集团股份有限公司位于山东省淄博市张店区华光路366号科创大厦B座9 层，成立日期2003年1月29日，上市日期2012年8月1日，公司主营业务涉及聚氨酯硬泡组合聚醚的技术 研发、生产与销售,互联网广告营销业务。主营业务收入构成为：含氟新材料73.60%，聚氨酯新材料 25.86%，其他0.54%。 分红方面，ST联创A股上市后累计派现2.04亿元。近三年，累计派现0.00元。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@s ...

Group 1 - The stock of Yazhen Home Co., Ltd. (*ST亚振) has experienced a significant increase, with 6 limit-up days in the last 10 trading days, resulting in a cumulative increase of 50.35% and a turnover rate of 10.76% [2] - As of 14:58, the stock's trading volume reached 2.2622 million shares, with a transaction amount of 106 million yuan, and a turnover rate of 0.86% [2] - The total market capitalization of A-shares has reached 12.491 billion yuan [2] Group 2 - The stock has appeared on the Dragon and Tiger List twice due to a cumulative closing price deviation of 12% over three consecutive trading days, with a net selling amount of 2.1107 million yuan from the leading brokerage firms [2] - The company was established on August 15, 2000, with a registered capital of 262.752 million yuan [2] - Recent trading data shows fluctuating daily price changes and net capital inflows, with notable negative net inflows on several days, including a peak of -3260.35 million yuan on December 19, 2025 [2]

Group 1 - The stock of *ST Panda has experienced significant volatility, achieving four trading limit-ups within seven trading days, resulting in a cumulative increase of 24.76% and a turnover rate of 24.77% [2] - As of 14:25, the stock recorded a trading volume of 9.68 million shares and a transaction amount of 98.40 million yuan, with a turnover rate of 5.83% [2] - The total market capitalization of A-shares reached 1.74 billion yuan [2] Group 2 - The stock has been listed on the Dragon and Tiger list due to a cumulative price deviation of 12% over three consecutive trading days [2] - The net buying amount from the leading brokerage firms on the Dragon and Tiger list was 112,900 yuan [2] - Panda Financial Holdings Co., Ltd. was established on December 12, 1999, with a registered capital of 166 million yuan [2] Group 3 - Recent stock performance data shows fluctuations in daily price changes and turnover rates, with notable increases on December 18 (5.00%) and December 22 (4.96%) [2] - The stock experienced a decline of 3.20% on December 25, with a net outflow of 752,640 yuan in main funds [2] - The highest net inflow of main funds was recorded on December 23, amounting to 430,630 yuan [2]

Group 1 - *ST Panda has experienced a significant increase, with three limit-up days within four trading days, resulting in a cumulative increase of 19.17% and a cumulative turnover rate of 4.33% [2] - As of 9:25 AM, the stock's trading volume was 44,700 shares, with a transaction amount of 447,400 yuan, and a turnover rate of 0.03% [2] - The latest total market capitalization of A-shares reached 1.662 billion yuan [2] Group 2 - The stock has been listed on the Dragon and Tiger List due to a cumulative closing price deviation of 12% over three consecutive trading days, with a net buying amount of 112,900 yuan from the leading brokerage firms [2] - Panda Financial Holdings Co., Ltd. was established on December 12, 1999, with a registered capital of 166 million yuan [2] - Recent performance data shows fluctuations in daily price changes, with notable increases of 4.96%, 2.95%, and 5.00% on December 22, 19, and 18, respectively [2]

Core Viewpoint - *ST Yuanshang has experienced significant stock price fluctuations, achieving 8 limit-up days within 13 trading days, with a cumulative increase of 25.14% and a turnover rate of 20.83% [2] Trading Performance - As of 14:05, the stock recorded a trading volume of 1.2086 million shares and a transaction amount of 45.9353 million yuan, with a turnover rate of 1.15% [2] - The stock has appeared on the Dragon and Tiger List three times due to a cumulative closing price deviation of 12% over three consecutive trading days, with a net selling amount of 36.9154 million yuan from the leading trading departments [2] Financial Performance - In the third quarter, the company reported a total operating income of 335 million yuan, representing a year-on-year increase of 38.57%, while the net profit was -40.5377 million yuan, a year-on-year decrease of 40.75%, resulting in a basic earnings per share of -0.3900 yuan [2] Company Background - Guangdong Yuanshang Logistics Co., Ltd. was established on August 15, 2005, with a registered capital of 105.015 million yuan [2]

Core Insights - *ST Wanfang has experienced significant stock performance, achieving three trading halts within five days and a cumulative increase of 5.15% [2] - The company reported a total revenue of 176 million yuan for the first three quarters, marking a year-on-year growth of 60.43%, while net profit decreased to -8.59 million yuan, a decline of 164.64% [2] Stock Performance - The stock recorded a trading volume of 10.4861 million shares today, with a transaction value of 59.2513 million yuan and a turnover rate of 3.38% [2] - The total market capitalization of A-shares reached 1.781 billion yuan, with a circulating market value of 1.774 billion yuan [2] Recent Trading Data - The stock's daily performance over the past week shows fluctuations, with notable declines on November 14 and 19, and increases on November 17 and 18 [2] - The net inflow of main funds has been negative for several days, indicating potential selling pressure from investors [2]

Group 1 - The stock *ST Baoying has experienced a significant increase, recording 14 limit-up days within 16 trading days, with a cumulative increase of 80.91% and a turnover rate of 31.25% [2] - As of 9:25, the stock's trading volume reached 1.1429 million shares, with a transaction amount of 4.983 million yuan, and a turnover rate of 0.08% [2] - The total market capitalization of A-shares is currently 6.611 billion yuan, with a circulating market capitalization also at 6.611 billion yuan [2] Group 2 - The stock has appeared on the Dragon and Tiger list four times due to a cumulative closing price deviation of 12% over three consecutive trading days, with institutional net selling of 5.0314 million yuan and a total net buying of 46.8756 million yuan from brokerage seats [2] - The company's third-quarter report indicates a total operating revenue of 515 million yuan, a year-on-year decrease of 65.79%, and a net profit of -33.7475 million yuan, a year-on-year increase of 92.21%, with basic earnings per share at -0.0200 yuan [2] - Shenzhen Baoying Construction Holdings Group Co., Ltd. was established on April 30, 1993, with a registered capital of 1.516248693 billion yuan [2]

Core Viewpoint - ST诺泰 is experiencing a positive market response with a slight increase in stock price and significant trading volume, indicating investor interest in the company's growth potential in the pharmaceutical sector [1]. Group 1: Business Overview - The company specializes in custom products, primarily through its CDMO (Contract Development and Manufacturing Organization) business, which emphasizes the integration of process development and technical innovation [2]. - ST诺泰 has received clinical trial approval for its self-developed GLP-1 receptor agonist, SPN0103-009, aimed at treating diabetes and obesity [2]. - The company’s product, Thymosin Alpha 1 injection, is used for treating chronic hepatitis B [3]. - The approval of Oseltamivir Phosphate capsules allows the company to market an antiviral drug for treating and preventing influenza in adults and children [3]. - As of the 2024 annual report, overseas revenue accounts for 63.12% of total revenue, benefiting from the depreciation of the RMB [4]. Group 2: Financial Performance - For the period from January to September 2025, ST诺泰 reported revenue of 1.527 billion yuan, a year-on-year increase of 21.95%, and a net profit attributable to shareholders of 445 million yuan, up 26.92% year-on-year [8]. - The company has distributed a total of 362 million yuan in dividends since its A-share listing, with 330 million yuan distributed over the past three years [9]. Group 3: Market Activity - The stock has seen a net inflow of 21.6999 million yuan today, with a continuous increase in main funds over the past three days [5]. - The average trading cost of the stock is 41.70 yuan, with the stock price approaching a resistance level of 40.22 yuan, indicating potential for upward movement if this level is surpassed [7].

Core Insights - *ST Dongyi has experienced a significant stock price increase, recording 23 trading limit-ups within 28 trading days, with a cumulative increase of 241.59% and a turnover rate of 178.85% [2] - The company's latest quarterly report shows a substantial decline in revenue, with a total operating income of 544 million yuan, down 52.02% year-on-year, and a net loss of 58.26 million yuan, although this represents an 89.97% increase in losses compared to the previous year [2] - The stock has been actively traded, with a total trading volume of 132,500 shares and a transaction amount of 2.34 million yuan on the latest trading day [2] Trading Activity - The stock has been listed on the "Dragon and Tiger List" for ST securities due to a cumulative closing price deviation of 12% over three consecutive trading days [2] - Institutional investors have shown a net selling trend, with a total net sell of 2.7362 million yuan from institutions and a combined net sell of 11.2 million yuan from brokerage seats [2] - The stock's daily trading performance indicates fluctuating net inflows and outflows of capital, with notable negative net inflows on several days, such as -25.41 million yuan on October 23 [3]